The stock market showed continued strength on Wednesday following Monday’s opening selloff over tariff worries. The rebound off the lows comes after tariffs were delayed for a month on Mexico and Canada but not on China. The Nasdaq closed at 19,692 (+0.2%) with the high hitting 19,696. Resistance at 19,750 held. Support is at 19,500. The S&P 500 traded up to 6,062 before ending at...
Continue reading >>
The tariff war starts in February with initial estimates ranging from 10%-25%. Companies in the defense and aerospace sectors and Raw Materials and Commodities Producers could benefit. The logistics and shipping industries could be impacted, but companies that offer domestic transportation solutions might benefit from increased demand for goods. [video width="900px"...
Continue reading >>
The tariff war starts in February with initial estimates ranging from 10%-25%.Companies in the defense and aerospace sectors and Raw Materials and Commodities Producers could benefit.The logistics and shipping industries could be impacted, but companies that offer domestic transportation solutions might benefit from increased demand for...
Continue reading >>
The tariff war starts in February with initial estimates ranging from 10%-25%.Companies in the defense and aerospace sectors and Raw Materials and Commodities Producers could benefit.The logistics and shipping industries could be impacted, but companies that offer domestic transportation solutions might benefit from increased demand for...
Continue reading >>
[embed]https://vimeo.com/1049295901[/embed]For investors that missed Nvidia’s (NVDA) incredible triple-digit return of 145% in 2024 and the stock’s five-year return of over 2,000%, many feel as though they may have missed the artificial intelligence (AI) boom. The good news is that the AI revolution spans several sectors, from cloud computing and semiconductor manufacturing to software...
Continue reading >>
by Market Updates and Alerts BRISTOL MYERS SQUIBB TO ACQUIRE TURNING POINT AT $76 SHARE Turning Point Therapeutics (NASDAQ: YPTX) was up 118.35% after announcing a merger agreement with Bristol Myers Squibb (NYSE: BMY). Bristol Myers Squibb will purchase Turning Point Therapeutics at $76 per share, according to the agreement terms. The Board of directors of both companies unanimously approved...
Continue reading >>